Use of the molecular adsorbents recirculating system as a treatment for acute decompensated Wilson disease

Liver Transplantation

Volumn 14, Issue 10, 2008, Pages 1512-1516

  Chiu, Alexander ^a   Tsoi, Nai Shun ^a   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CERULOPLASMIN; COPPER; CREATININE; HEMOGLOBIN; LACTULOSE; NITROGEN; PENICILLAMINE; UREA; VITAMIN K GROUP;

ABDOMINAL DISTENSION; ACUTE DECOMPENSATED WILSON DISEASE; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN DIALYSIS; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR SYSTEM; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; CHOLESTASIS; CIRCULATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG DOSE INCREASE; EARLY INTERVENTION; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; INTRAVASCULAR HEMOLYSIS; KIDNEY FUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; OLIGURIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; RETICULOCYTE COUNT; RISK REDUCTION; TREATMENT FAILURE; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; VOMITING; WILSON DISEASE;

ADOLESCENT; ADSORPTION; COPPER; FEMALE; HEMODIAFILTRATION; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER TRANSPLANTATION; MALE; YOUNG ADULT;

EID: 57849094542     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21553     Document Type: Article

References (19)

1. Sherlock S, Dooley J. Wilson disease. In: Sherlock S, Dooley J, eds. Diseases of the Liver and Biliary System. 11th ed. Oxford, England: Blackwell Science; 2002:413-422.
2. Schilsky M, Tavill AS. Wilson disease. In: Schiff ER, Sorrell M, Maddrey W, eds. Schiff's Disease of the Liver. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003: 1169-1186.
3. Davies SE, Williams R, Portmann B. Hepatic morphology and histochemistry of Wilson's disease presenting as fulminant hepatic failure: a study of 11 cases. Histopathology 1989;15:385-394.
4. Lee VD, Northup PG, Berg CL. Resolution of decompensated cirrhosis from Wilson's disease with zinc monotherapy: a potential therapeutic option? Clin Gastroenterol Hepatol 2006;4:1069-1071.
5. United Network of Organ Sharing. Organ distribution: policy on allocation of livers. Available at: http://www.unos.org/ policiesandbylaws2/policies/pdfs/policy_8.pdf. Accessed November 2007.
6. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO J 1993;39:M621-M625.
7. Chiu A, Fan ST. MARS in the treatment of liver failure: controversies and evidence. Int J Artif Organs 2006;29: 660-667.
8. Chiu A, Chan LM, Fan ST. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. Liver Int 2006;26:695-702.
9. McIntyre N, Clink HM, Levi AJ, Cumings JN, Sherlock S. Hemolytic anemia in Wilson's disease. N Engl J Med 1967; 276:439-444.
10. Hamlyn AN, Gollan JL, Douglas AP, Sherlock S. Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens. Br Med J 1977;2:660-662.
11. Manz T, Ochs A, Bisse E, Strey C, Grotz W. Liver support - a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis. Blood Purif 2003;21:232-236.
12. Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olausson M, et al. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Liver Transpl 2002;8:962-967.
13. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999;31:1080-1085.
14. Kiss JE, Berman D, Van Thiel D. Effective removal of copper by plasma exchange in fulminant Wilson's disease. Transfusion 1998;38:327-331.
15. Jhang JS, Schilsky ML, Lefkowitch JH, Schwartz J. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease. J Clin Apher 2007;22: 10-14.
16. Aydinli M, Harmanci O, Ersoy O, Iskit AT, Ozcebe O, Abbasoglu O, Bayraktar Y. Two unusual cases with Wilson's disease: hepatoma and fulminant hepatitis treated with plasma exchange. J Natl Med Assoc 2006;98:1989-1991.
17. Medici V, Mirante VG, Fassati LR, Pompili M, Forti D, Del Gaudio M, et al. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transpl 2005;11:1056-1063.
18. Guarino M, Stracciari A, D'Alessandro R, Pazzaglia P. No neurological improvement after liver transplantation for Wilson's disease. Acta Neurol Scand 1995;92:405-408.
19. Kassam N, Witt N, Kneteman N, Bain VG. Liver transplantation for neuropsychiatric Wilson disease. Can J Gastroenterol 1998;12:65-68.